Clinical advantages and efficacy of sleeve gastrectomy in the treatment of non-alcoholic fatty liver disease
- PMID: 40342769
- PMCID: PMC12057514
- DOI: 10.21037/hbsn-2025-2
Clinical advantages and efficacy of sleeve gastrectomy in the treatment of non-alcoholic fatty liver disease
Keywords: Bariatric surgery; fibrosis; non-alcoholic fatty liver disease (NAFLD); obesity.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-2025-2/coif). L.Z. reports grants from the Key Research and Development Program of Hunan province (No. 2022SK2001) and the General Program of National Natural Science Foundation of China (No. 82370676). The other authors have no conflicts of interest to declare.
Comment on
-
Foregut bypass vs. restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals.Hepatobiliary Surg Nutr. 2023 Oct 1;12(5):658-670. doi: 10.21037/hbsn-21-520. Epub 2022 Jun 20. Hepatobiliary Surg Nutr. 2023. PMID: 37886204 Free PMC article.
References
-
- Li L, Liu DW, Yan HY, et al. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev 2016;17:510-9. - PubMed
-
- Sheka AC, Adeyi O, Thompson J, et al. Nonalcoholic Steatohepatitis: A Review. JAMA 2020;323:1175-83. - PubMed
-
- Lassailly G, Caiazzo R, Ntandja-Wandji LC, et al. Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis. Gastroenterology 2020;159:1290-1301.e5. - PubMed
-
- Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis 2022;18:1345-56. 10.1016/j.soard.2022.08.013 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources